Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal Injections
Rachel Israilevich, Hana A. Mansour, Samir Patel, Sunir J. Garg, Michael A. Klufas, Yoshihiro Yonekawa, Carl D. Regillo, Jason Hsu
Topics & Concepts
MedicineEndophthalmitisRanibizumabInterquartile rangeOphthalmologyCumulative doseBevacizumabAfliberceptSurgeryRetrospective cohort studyChemotherapyOcular Infections and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Diseases and Treatments